Safety and Success of Implanting Venous Access Devices by Anesthesiologists
Author Information
Author(s): Muacevic Alexander, Adler John R, Valls Nicolás, Villablanca Nicolás, González Roberto, Ramirez María Soledad, Almeida Carla, Lopez Julio
Primary Institution: National Cancer Institute, Santiago, CHL
Hypothesis
The implantation of totally implantable venous access devices (TIVADs) by anesthesiologists is safe and effective in oncology patients.
Conclusion
The implantation of TIVADs by anesthesiologists in cancer patients was predominantly successful and safe, with a low complication rate.
Supporting Evidence
- The success rate for the first attempts was 91%.
- Infectious complications were documented in six patients (1.1%).
- Non-infectious complications manifested in less than 1% of cases.
Takeaway
Doctors put in special devices to help cancer patients get their medicine easily, and they did it safely with very few problems.
Methodology
This retrospective cohort study included all oncology patients 18 years or older who underwent TIVAD implantation between September 2015 and October 2019, with data obtained from clinical records.
Limitations
The study has a short follow-up period of up to five years, which may not capture all late complications.
Participant Demographics
The cohort included 556 patients, with 58% being female and an average age of 53 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website